LEADER 03134nam 2200397 450 001 9910765757603321 005 20230326233154.0 010 $a3-03842-190-1 035 $a(CKB)5400000000000397 035 $a(NjHacI)995400000000000397 035 $a(EXLCZ)995400000000000397 100 $a20230326d2016 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aForty Years of Heel Prick Screening in the Netherlands $eVeertig Jaar Hielprikscreening in Nederland /$fJ. Gerard Loeber and Carla G. van El 210 1$aBasel :$cMDPI,$d2016. 215 $a1 online resource (114 pages) $cillustrations 327 $aChapter 1 : The Start and expansion of the heel prick screening programme -- Chapter 2 : Organisational aspects, windfalls and setbacks -- Chapter 3 : The heel prick screening programme in its current form -- Chapter 4 : Newborn blood spot screening in other countries -- Chapter 5 : Summary and the conclusions. 330 $aThis book aims to provide an overview of developments in the heel prick screening programme in the Netherlands in which similarities with the situation elsewhere in the world, where relevant, will be mentioned. In the Netherlands, the preparations for the national screening programme started in 1964. The formal launch of the programme was on September 1, 1974. In 2014, therefore this programme had existed 40 years. The book is structured as follows. Chapter 1 describes how the programme began with one disease and over the years has continued to expand to currently covering 19 disorders. Chapter 2 focuses on the organisation of the screening programme and the agencies that have been involved over the years. Chapter 3 is intended to provide a global view of the programme in its current form. Chapter 4 describes how neonatal screening programmes elsewhere in the world developed and outline their main differences with the Dutch programme. Finally, Chapter 5 contains the summary and conclusions. This chosen structure leads to some aspects being mentioned more than once. The book is intended for a broad audience that is interested in policy making on heel prick screening; hence, scientific depth is limited. Where possible and useful, references to the scientific literature have been included but completeness has not been pursued. The main sources were the archives of the National Steering Committees for Phenylketonuria and Congenital Hypothyroidism (LBCs), supplemented with interviews with the persons listed in Annex 1 and, if available, their personal archives. 517 $aForty Years of Heel Prick Screening in the Netherlands 606 $aMedical screening 606 $aScientific literature 615 0$aMedical screening. 615 0$aScientific literature. 676 $a362.177 700 $aLoeber$b J. Gerard$01367760 702 $aEl$b Carla van 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910765757603321 996 $aForty Years of Heel Prick Screening in the Netherlands$93391567 997 $aUNINA